Sun Pharma’s subsidiary DUSA Pharmagets preliminary injunctive relief prohibiting Biofrontera from using its trade secrets
DUSA PharmaceuticalsInc., the wholly owned subsidiary of Sun Pharmaceutical Industries Ltd,has announced that DUSA has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera
USA UK Ireland scientist partner AMTZ to further biomaterials research
At a recently held event, AMTZ and KIHT brought the bio-materials community together and exchanged ideas on how the entire ecosystem can promote indigenous products researched at Indian institutions of merit.
China’s HitGen Bayer enter DNA-encoded library-basedresearch collaboration
“Our research and development (R&D) platforms are supplemented by what we call an ‘open innovation’ model,” said Axel Trautwein, Head of Small Molecules, Crop Science division of Bayer. “HitGen’s experience in DNA-encoded chemistry fits that model well, and we look forward to using their advanced technology platform to develop solutions that help farmers control existing crop threats and get ahead of emerging ones.”